<DOC>
	<DOC>NCT01093638</DOC>
	<brief_summary>The study will evaluate the effect of oral formulation of insulin on preterm infants, born between 26-33 weeks of pregnancy, weighing over 750 grams, who meet the inclusion and exclusion criteria established in this protocol.</brief_summary>
	<brief_title>Oral Formulation of Insulin for Preterm Infants</brief_title>
	<detailed_description>The study will aim to determine whether an oral formulation of insulin administration enhances gastrointestinal maturation. The gastrointestinal maturation will be evaluated by the ability of premature infants to achieve complete enteral feeds. The insulin concentration administered in the study is physiological and within the insulin concentration range present in human breast milk and colostrum.</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>1. Preterm infants 2633 weeks gestation.</criteria>
	<gender>All</gender>
	<minimum_age>26 Weeks</minimum_age>
	<maximum_age>33 Weeks</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>